Business Context and Reporting Period
This Form 8-K Current Report was filed by The Cigna Group (formerly Cigna Corporation) on February 13, 2023. The filing documents a corporate name change effective as of the report date, pursuant to a certificate of amendment to the restated certificate of incorporation filed with the Delaware Secretary of State.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly administrative and does not contain financial performance data.
Material Changes
- Corporate Name: Changed from "Cigna Corporation" to "The Cigna Group" effective February 13, 2023.
- Governance Documents: The Company amended and restated its by-laws and filed a restated certificate of incorporation to reflect the new name.
- Shareholder Rights: The name change does not affect the rights of shareholders, creditors, customers, or suppliers, and no shareholder vote was required.
Outlook and Trading Information
The Company's common stock will continue to trade on the New York Stock Exchange under the ticker symbol "CI". Trading under the former name, Cigna Corporation, will continue through February 22, 2023. Trading under the new name, The Cigna Group, will commence on February 23, 2023. The CUSIP and trading symbol remain unchanged.
Key Facts for Investors
- The corporate name change is effective immediately as of February 13, 2023.
- The stock ticker symbol "CI" remains unchanged.
- The name change is a cosmetic update to the corporate charter and by-laws with no impact on shareholder rights or financial obligations.
- Supporting legal documents (Certificate of Amendment, Restated Charter, and Amended By-laws) are filed as Exhibits 3.1, 3.2, and 3.3.